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geographical barriers while 63.5% and 58.5 % of them are in front of economic and 
waiting list barriers, respectively. More likely to face economic barriers in access are 
unemployed patients [coef.0.55; 95% CI (0.1, 1)] and patients with low income [-0.2; 
95% CI (-0.26,-0.13)] and lower educational level [-0.04; 95% CI (-0.08, 0)]. Women 
[0.22; 95% CI(0.02,0.42)], low-income patients [-0.13 ; 95% CI(-0.2, -0.06)], and patients 
with lower health status [-0.02 ; 95% CI(-0.02,-0.01)] are more likely to be in front 
of geographical barriers in access. Moreover, all occupational categories examined, 
demonstrate a statistically significant positive relationship with the probability of 
geographical barriers occurrence. In addition, unemployed patients [0.51; 95% CI 
(0.06, 1)], public or private sector employees [0.45; 95% CI (0.09, 0.81)] and low income 
patients [-0.086; 95% CI (-0.15, 0.02)] are more likely to deal with barriers attributed 
to waiting lists. ConClusions: Chronic patients face extensive barriers in access, 
which can mainly be explained by the fall of income, the rise of unemployment 
and the policy of decreasing the supply of certain health services in order to reduce 
health expenditure. If such barriers won’t be minimized inequalities will be enlarged 
and chronic patients’ health status will be worsened which might lead to increased 
future costs and adverse effects on health expenditures.
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objeCtives: From 2011, there are basic thresholds (λ 1= 24 x average monthly sal-
ary € / QALY and λ 2 = 35 x average monthly salary € / QALY) defined directly in the 
Slovak legislation reflecting the benefits displaced elsewhere in the Slovak health 
care system when funds are allocated to new medicines and medical devices. The 
objective of this study was to analyse the quality of submitted economic studies, 
related critical appraisals process and impacts of the new legislation on the access 
to medicines and medical devices. Methods: We created a working group to review 
previously submitted economic evaluations and related critical appraisals in order 
to identify potential technical and methodological problems. The working group 
scrutinized previous submissions and critical appraisals, concerning to chosen ATC 
groups of drugs and groups of medical devices, published between June 2012 and 
June 2013 at the webside of MoH. Results: Pharmacoeconomic evaluations of drugs 
and medical devices within decision making process concerning to reimbursement 
are mandatory but the quality of studies are very often rather poor. The concept “the 
QALY is a tool not a rule” was slightly modified in Slovakia. Our analysis shows that 
implicit thresholds included into the Slovak legislation have influenced decision-
making process concerning to drugs and medical devices. In the defined time period 
4 drugs exceeded the basic thresholds described in the Slovak legislation, however 
108 drugs and medical devices were refused to include into the reimbursement 
list, because of the poor quality of provided pharmacoeconomic studies from the 
side of applicants. ConClusions: The transparent method of HTA can improve 
the consistency of reimbursement decisions making related to drugs and medical 
devices in Slovakia. However significant improvements in the quality of submitted 
pharmacoeconomic dossiers have to be the first step towards the better access to 
drugs and medical devices for the Slovak patients.
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objeCtives: Developed countries have embraced the purchaser-provider split as 
a mechanism to improve health resource allocation and outcomes. With the emer-
gence of Clinical Commissioning Groups (CCGs) as both buyers and providers of 
health services a hybrid purchaser-provider model is being explored. This research 
explored the opportunities and challenges of this model and analysed the impli-
cations for NHS England and Europe. Methods: Eighty influential regional and 
national payers involved in the NHS England reforms took part in 1-hour tele-depth 
interviews to better understand the changes and uncertainties before the reforms 
were implemented. This research was re-visited three months post implementa-
tion in an advisory board setting to externally validate our findings and identify 
case studies for further analysis. Results: NHS payers stated that they were still 
‘broadly optimistic’ about the re-allocation of purchaser responsibilities to CCGs. 
One case study illustrated that greater clinician involvement provided opportuni-
ties to redesign services like respiratory care and allocate funding more efficiently 
between acute and primary care. Initial success stories include the creation of 
primary care diabetes clinics and Pharma-NHS local partnerships to help reduce 
hospital activity. Within the advisory board, payers voiced concerns with this hybrid 
model. Questions raised from the meeting included: 1) How do we equip GP commis-
sioners with the right skill set to draft and negotiate hospital contracts? 2) How can 
we help GP commissioners and GP providers to help minimise potential conflicts of 
interest? ConClusions: The purchaser-provider model implemented in England 
presents a new way to tackle reduced financial budgets and need to improve health 
outcomes. The results of this research suggest that the purchaser-provider model 
has the potential to make a difference for patient care. A number of challenges 
appear to still be present and it will be important to address these in order for the 
UK and other countries to further explore its benefits.
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Drug Interaction Facts. Results: A highly significant difference was observed 
between the prevalence of pDDIs in prescriptions from hospital (45%; 180 out of 
400 prescriptions with at least 1 pDDI) and community pharmacies (29.25%; 117 
out of 400 prescriptions with atleast 1 pDDI). On the whole, out of total 543 pDDIs 
(hospital = 337; community = 206) majority of them were of delayed onset (hospital 
= 50.44%, community = 44.66%), moderate severity (hospital = 57.87%, community 
= 42.72%), suspected type (hospital = 27.6%) and possible documentation (com-
munity = 14.08%). Most of the prescriptions (hospital = 80%; community = 83%) 
contained 2-4 medicines. The interacting combinations such as aspirin-clopidogrel 
omeprazole-clopidogrel and digoxin-furosemide (in hospital); isoniazid-rifampin 
and tramadol-escitalopram were found to be frequently involved in major inter-
actions. The findings showed that cardiovascular drugs were involved in most of 
the rapid pDDIs (in hospital = 32.46%; in community = 33.33%) and respiratory 
system drugs were associated with majority of established documented pDDIs (in 
hospital = 16.67%; in community = 42.86%). ConClusions: Drug-drug interac-
tions in prescription medicines were observed in high percentage both in hospitals 
and community pharmacies. Clinical practices must be standardized as rational 
prescribing practices.
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objeCtives: To examine access of migrants in health care services, their unmet 
health needs, and the factors associated with these. Methods: A cross-sectional 
pilot study was conducted from January to May 2013. The study population consisted 
of 231 recent immigrants living in Greece. A questionnaire was developed including 
information about demographics, health status, difficulties in health services access 
etc. Statistical analysis included Pearson’s x2 test, x2test for trend, student’s t-test, 
analysis of variance and Pearson’s correlation coefficient. Results: Almost half of the 
participants (n= 115, 49.7%) used public health services in the last 12 months in Greece. 
Among them, 56.8% (n= 131) used emergency department services. A considerable 
proportion of the participants (n= 144,62.3%), during the last year, needed at least one 
time to use health services but they could not afford it. The most important reasons 
for that were high cost of health care (n= 80, 34.5%) and the long waiting lists (n= 29, 
12.6%). More than half of the participants (n= 122, 52.9%) reported that they had major 
difficulties in accessing health services. Increased family monthly income was associ-
ated with decreased difficulties in access in health services (x2 test for trend= 32.1, 
p< 0.001). The use of preventive services has been limited since more than 60% of 
the women 40+ reported not having conducted a pap test or a mammography, while 
more than 30% of the respondents were not subjected to a blood test or a cholesterol 
examination. ConClusions: Barriers to health services access for migrants may 
lead to decreased use of health services, especially primary, and thus lead to increased 
hospitalizations and higher cost in the longer-run. Formulation of policies to improve 
access and use of health care services are necessary.
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objeCtives: Cost effectiveness analyses play a critical role in determining coverage 
of novel drugs and devices. Increasingly, payers are demanding subgroup analyses 
to determine indications which would be covered by the national health system or 
insurance agency. Methods: To understand and review trends in the use of subgroup 
cost effectiveness analysis, we analyzed NICE HTAs for products approved between 
2011-2012. Manufacturer submissions for CEA were compared to final review and 
decision by HTA agency. Analogs were identified and case studies were developed 
to further understand the use of subgroup analyses and cost effectiveness mod-
els. Results: Decisions made by NICE in 2011-2012 show increasing trends towards 
the use of subgroup analysis for determining indications for coverage by national 
payer bodies. Between 2011-2012, 80% of the assessments included subgroup analy-
ses. Approximately half of them included cost effectiveness analyses for various 
subgroups. Interestingly, the ICER values estimated by NICE for the same subgroups 
showed a large variation (1X-3X fold difference) compared to ICER values estimated 
by manufacturers. Selected case studies highlighted that for several products, NICE is 
recommending treatments only for subgroups whose ICER values are within the cost 
effectiveness threshold. ConClusions: New products need robust broader popula-
tion and subgroup analyses for insurance coverage.
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objeCtives: To explore the magnitude of certain access barriers to physician ser-
vices that chronic patients are in front of as well as which patients are more vul-
nerable to such restrictions. Methods: A cross-sectional study was conducted in 
1600 chronic patients suffering from diabetes, hypertension, COPD and Alzheimer. 
Logistic regression analysis was carried out in order to explore the factors related 
to economic and geographical barriers in access, as well as the determinants of 
barriers imposed by waiting lists. Results: A total of 25% of chronic patients face 
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objeCtives: To identify the extent to which patients accept the measure of cost 
sharing fee (5€ ) in public primary health care units (health centers and hospitals’ 
outpatient departments) as well as to investigate whether patients perceive the 
potential benefits of the measure for the quality improvement of provided health 
care. Methods: The study population consisted of 1260 people, who used public 
primary health care units. A structured questionnaire was used, including ques-
tions for patients’ demographic characteristics, their attitude regarding the cost 
sharing mechanism (compliance, perception of the benefits for health services 
upgrade etc), and their level of satisfaction with the provided services. Results: 
The implementation of cost sharing mechanism was positively accepted by 30% 
of respondents. Approximately 90% of the respondents, who expressed positive 
opinion for the implementation of the mechanism, considered that it would provide 
financial support to health units. Among the respondents who expressed negative 
opinion for the measure, 95% believed that health services should be public and free 
for everyone, 83% expressed lack of confidence that the measure aims at upgrading 
the provided services, 78% believed that the insurance contributions they already 
pay are high and 67% stated no financial comfort. The negative opinions were more 
frequent among people with lower socio-economic profile and those who have used 
health centers (p< 0.06). Respondents with higher socio-economic profile, coming 
from urban areas and respondents who were very satisfied with health services 
had statistically significantly greater possibility to express positive opinion for the 
measure. ConClusions: Low socio-economic profile is negatively associated with 
the acceptance of the implementation of cost sharing mechanism, while high satis-
faction with services is positively associated with the acceptance of the mechanism. 
The majority of those, who expressed positive opinion for the measure, consider it 
as a contribution to the enhancement of health services.
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objeCtives: Financial incentives or Pay-for-Performance (P4P) have become a 
common approach to improve the quality in health care. Although the effective-
ness is mixed, more and more P4P initiatives are implemented. Besides the desired 
effects of quality improvement, a growing number of evaluations show that finan-
cial incentives lead to unintended consequences. Therefore this study analyses 
negative effects of P4P. Methods: On the basis of a systematic review of system-
atic reviews regarding P4P in health care (nine systematic reviews included that 
evaluate 75 different primary studies; Methodological quality assessment using the 
AMSTAR checklist) an additional hand search was conducted to identify evidence of 
unintended consequences of P4P. Results: Both theory and evidence of financial 
incentives demonstrate the potential of negative effects. Risk selection is identified 
in six reviews: Patients could get selected due to their severity of illness in order 
to achieve quality targets with minimum effort (cherry picking); Physicians will 
focus on indicators or aspects of care that are linked to payments (teaching to the 
test). Focussing on incentivized indicators could lead to quality decrease in non-
incentivized indicators (negative spillover effects), assessed in four reviews. Five 
reviews show that physicians could game the P4P program by reporting incorrect 
results and therefore increase their payments (gaming). Furthermore, improvements 
can be the result of better documentation and not actual quality improvements (four 
reviews). Finally one review identified crowding out of intrinsic motivation due to 
financial incentives. ConClusions: The available evidence shows that P4P can 
result in unintended consequences. Evaluations of P4P should include these effects 
in order to assess an overall effect and thereby determine the effectiveness of P4P. 
To avoid negative effects it is important to consider the potential of unintended 
consequences and develop appropriate solutions.
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objeCtives: Home care (nursing) was introduced into the Hungarian basic health 
insurance package in 1996. The aim of our study is to analyze the geographical ine-
qualities in the access to and utilization of that services in Hungary. Methods: Data 
were derived from the nationwide administrative dataset of the National Health 
Insurance Fund Administration (OEP), the only health care financing agency in 
Hungary. The geographical inequalities in home care (nursing) services were meas-
ured by the number patients, visits and reimbursement according to 20 Hungarian 
counties. We analyzed the year 2011. Results: The national average number of 
patients was 51 patients / 10000 population. We found the highest patient number 
in county Zala (67), Jász-Nagykun-Szolnok (63) and Baranya (62), while the lowest 
number in county Békés (43), Somogy (43) and Szabolcs-Szatmár-Bereg (28). The 
national average number of home visits was 1193 visits / 10000 population. We found 
the highest number of visits in county Nógrád (1494), Tolna (1385) and Fejér (1377), 
while the lowest number in county Somogy (1138), Csongrád (1106) and Szabolcs-
Szatmár-Bereg (678). The national average of reimbursement per patient was 65345 
objeCtives: Electronic-prescribing (E-prescribing) in comparison to manual (“by 
hand”) generation, transmission and filling of prescriptions is thought to substan-
tially lower the risks of inaccuracy and therefore reduce associated health care 
resource use and costs. The purpose of this work is to describe the current state of 
e-prescribing systems implementation in Denmark, Germany, Italy, Poland, United 
Kingdom (UK) and United States (USA), and to assess present evidence of its influ-
ence on health care. Methods: A systematic review supplemented by additional 
hand-search was conducted to find relevant articles. Medline, Embase, The Cochrane 
Library and Scopus were searched. Quality was assessed on the basis of PRISMA, 
MOOSE and STROBE checklists and West 2002 recommendations. Results: Thirty-
one relevant full texts were identified during systematic review, and then as a result 
of hand-search, 5 publications were added. E-prescribing varies considerably across 
these countries. It is currently voluntary in Germany, Italy and United States. In 
United Kingdom the system is implemented except for electronic signature. In 
Denmark e-prescribing is mandatory for primary care providers. Model implemen-
tation in Poland is expected to take place in 2014. Of these 36 sources, 4 articles 
assessing e-prescribing were of the highest quality, as judged using the assessment 
methods. Positive influence on medical visits frequency, quality of care, patient 
satisfaction, prescription errors frequency, and prescriber-pharmacy-patient com-
munication was described in literature; most studies were conducted in the UK 
and USA. No data about effects of implementation for Germany, Italy, Denmark and 
Poland were found. ConClusions: Implementation of e-prescribing is in process 
in the majority of described countries. Although few studies exist that definitely 
demonstrate positive impact of e-prescribing on health care, gathered papers do 
indicate positive effects. More comprehensive assessments would be valuable in 
showing the attributes of e-prescribing that are most valuable, and those that may 
be strengthened.
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objeCtives: To review, describe and assess models of drug safety monitoring in 
England, Poland, Italy, Germany, Denmark and in the United States and prepare 
recommendations useful in health authorities decision-making process. Methods: 
A review of documents, materials and information published on national medicines 
agencies as well as WHO’s statements was conducted, supplemented by hand-
search of literature. Results: The advantages and disadvantages of described phar-
macovigilance schemes in selected countries has been discussed. The gathered data, 
related i.a. to the level of adverse drug reaction reporting in different countries, was 
used to assess the efficacy of national reporting process. Moreover our research 
allowed us to value the formula of pharmacovigilance schemes as well as the atti-
tudes of health care professionals and patients towards it. ConClusions: Although 
the majority of compared countries are European Union members bound to respect 
the same acts of European law, there are still many significant differences met in 
Pharmacovigilance practice reflecting in the level of adverse reaction reporting. 
These differences may be found as the treatment of newly registered medicines, 
data availability and transparency of procedures within the agencies or the relation-
ship between health authorities and potential reporters. A set of recommendations 
has been prepared related to special treatment of new medicines, creating aware-
ness of importance of pharmacovigilance in health care (hospitals, pharmacies), 
changing the attitude to risk aspects, transparency of safety monitoring practice 
and patients’ enrollment. The implication of our proposals could help to amend the 
pharmacovigilance systems in all discussed countries.
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objeCtives: To describe existing models of pharmaceutical care (PC) in England, 
Poland, Germany, Denmark, Italy and United States and to indicate similarities 
and specific attributes meant as differences (from the whole system point of view), 
identifying possibly promising solutions (promising means having preliminary or 
probably positive results described in found literature). Methods: A systematic 
and non-systematic literature review in Medline, Embase, Scopus and the Cochrane 
Library was performed. Quality of publications was critically appraised. Results: 
The review identified 48 full texts. The majority of papers were of moderate quality 
(PRISMA, MOOSE or STROBE checklists) and intermediate consistency, coherence 
and strength (West 2002). In chosen countries differences in the definition of PC 
have been noticed and therefore often it is difficult to find similarities. Although in 
some countries like England and the US, PC is firmly established and comparable 
with one another, in other it is very heterogeneous. Mainly in Central and Eastern 
Europe (CEE), especially in Poland, it is offered to a very limited extent or only pilot 
implementations exist. Four types of PC models have been distinguished: Anglo-
Saxon, Scandinavian, German and Italian. Specific attribute of English PC is division 
into essential, advanced and enhanced services. American pharmacists provid-
ing this service must be highly specialized. Danish system focuses on identifying, 
solving and prevention of drug-related problems. In Germany family pharmacy 
concept emerged. Pivotal point of Italian system is hospital PC. Identified promis-
ing solutions found in some countries were i.a. Drug Utilization Review, disease 
management programs or medicines use review. ConClusions: Identical PC con-
cept may be difficult to introduce in all EU Member States, due to differences in 
health systems. However, some identified, promising actions should be considered 
by decision makers and providers, as well as implementing PC to a sufficient extent 
in CEE countries.
